We have previously reported that syndecan-1 (CD138) up-regulates miR-331-3p expression by directly targeting neuropilin 2 (NRP2) and NACC1 to mediate the EMT in prostate cancer cells [12]. The gene discussed is NACC1; the disease is prostate carcinoma.